Pendulum Therapeutics Stock

pendulum.coHealthcare / BioTech & PharmaFounded: 2012Funding to Date: $121.76MM

Pendulum is a biotechnology company committed to developing novel interventions that target the human microbiome to improve the lives of patients suffering from a variety of diseases.

Register To Buy and Sell Shares

For more details on financing and valuation for Pendulum Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Pendulum Therapeutics’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Pendulum Therapeutics.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Colleen Cutcliffe Ph.D
Chief Executive Officer, Board Member & Co-Founder
Matthew Murphy JD
General Counsel
James Bullard Ph.D
Co-Founder, Chief Technology Officer & Secretary
John Eid Ph.D
Chief Scientific Officer, Board Member & Co-Founder
Mohan Iyer
Chief Operating Officer
Orville Kolterman
Chief Medical Officer

Board Members

Adam D'Augelli
True Ventures
Peter Hutt JD
Colleen Cutcliffe Ph.D
Hugh Martin
John Eid Ph.D
Roelof Botha
Sequoia Capital

Frequently Asked Questions About Pendulum Therapeutics’ Stock

plusminus
Can you buy Pendulum Therapeutics’ stock?
Pendulum Therapeutics is not publicly traded on NYSE or NASDAQ in the U.S. To buy Pendulum Therapeutics’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell Pendulum Therapeutics’ stock?
Yes, you can sell stock of a private company like Pendulum Therapeutics. Forge can help you sell your Pendulum Therapeutics stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus
What is Pendulum Therapeutics’ stock price?
Pendulum Therapeutics is a privately held company and therefore does not have a public stock price. However, you may access Pendulum Therapeutics’ private market stock price with Forge Data.
plusminus
What is Pendulum Therapeutics’ stock ticker symbol?
Pendulum Therapeutics does not have an official ticker symbol because this company is not currently publicly traded.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Whole Biome Announces Corporate Name Change to Pendulum Therapeutics
Sequoia-backed Whole Biome wants to heal your gut with medical-grade probiotics – TechCrunch
Whole Biome has pulled in $35 million in Series B financing from a list of investing titans, including Sequoia, Khosla, True Ventures, the Mayo Foundation and AME Ventues — just to name a few. The goal? To heal what ails you using microscopic bugs. Medical science has caught on in the last fe…
Whole Biome Raises $35M in Series B Financing | FinSMEs
Whole Biome, a San Francisco, CA-based evidence-based microbiome company, secured $35m in Series B financing. The round brings total funding to $57m
Updated on: Jun 17, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.